Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32561
Title: Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Austin Authors: Tan, Katrina;Testro, Adam G 
Affiliation: Victorian Liver Transplant Unit
Issue Date: 21-Mar-2023
Date: 2023
Publication information: BMJ Case Reports 2023; 16(3)
Abstract: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a multiorgan reaction associated with a broad range of commonly used medications. Most cases of DRESS syndrome resolve with cessation of the inciting agent; however, use of systemic immunosuppression, most commonly with oral corticosteroids, is also recommended in cases with visceral organ involvement.We report a case of steroid-resistant relapsing-remitting DRESS syndrome secondary to sulfasalazine. Our patient experienced significant flare of symptoms of DRESS syndrome with multiple attempts to wean prednisolone. Initiation of cyclosporine as an alternative immunosuppressive agent to long-term corticosteroids has resulted in a 6-month remission in both dermatological and hepatic sequelae of DRESS syndrome.
URI: https://ahro.austin.org.au/austinjspui/handle/1/32561
DOI: 10.1136/bcr-2022-250983
ORCID: 
Journal: BMJ Case Reports
PubMed URL: 36944441
ISSN: 1757-790X
Type: Journal Article
Subjects: Dermatology
Hepatitis other
Drug Hypersensitivity Syndrome/diagnosis
Drug Hypersensitivity Syndrome/drug therapy
Drug Hypersensitivity Syndrome/etiology
Cyclosporine/adverse effects
Immunosuppressive Agents/adverse effects
Eosinophilia/chemically induced
Eosinophilia/drug therapy
Steroids/therapeutic use
Adrenal Cortex Hormones/therapeutic use
Appears in Collections:Journal articles

Show full item record

Page view(s)

22
checked on May 16, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.